Ferroptosis Sensitive Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ferroptosis-Sensitive Neurons are neurons that are particularly vulnerable to ferroptosis, an iron-dependent form of non-apoptotic cell death characterized by lipid peroxidation. These neurons exhibit heightened sensitivity to ferroptotic cell death due to their unique metabolic properties and antioxidant defense mechanisms.
Ferroptosis was first recognized as a distinct cell death modality in 2012 and has since been implicated in various neurodegenerative diseases. Neurons are particularly susceptible to ferroptosis due to:
- High polyunsaturated fatty acid content in neuronal membranes
- High metabolic demand and iron accumulation
- Limited regenerative capacity
- Age-related decline in antioxidant systems
Ferroptosis-sensitive neurons typically exhibit:
- Elevated intracellular iron levels through transferrin receptor upregulation
- Increased ferritin expression as a compensatory mechanism
- Dysregulated iron export via ferroportin
The key features include:
- Accumulation of lipid reactive oxygen species (ROS)
- Depletion of glutathione peroxidase 4 (GPX4)
- Activation of lipoxygenases (LOX)
- Loss of membrane phospholipid asymmetry
flowchart TD
A[Iron Accumulation] --> B[ROS Generation] -->
B --> C[Lipid Peroxidation] -->
C --> D[GPX4 Depletion] -->
D --> E[Membrane Damage] -->
E --> F[Ferroptotic Cell Death] -->
G[System Xc-] -->|Inhibits| C
H[Ferrostatin-1] -->|Blocks| C
I[Liproxstatin-1] -->|Blocks| C
- Neurons in hippocampus and entorhinal cortex show ferroptosis susceptibility
- Iron accumulation observed in AD brain regions
- GPX4 levels decreased in AD patients
- Lipid peroxidation markers elevated in cerebrospinal fluid
- Dopaminergic neurons in substantia nigra particularly vulnerable
- Iron deposition in PD substantia nigra
- CoQ10 deficiency may exacerbate ferroptosis
- Ferroptosis inhibitors show neuroprotective potential in PD models
- Motor neurons exhibit ferroptosis sensitivity
- GPX4 mutations linked to ALS pathogenesis
- Ferroptosis contributes to disease progression in SOD1 models
- Striatal medium spiny neurons show ferroptotic features
- Mutant huntingtin affects iron metabolism
- Lipid peroxidation increased in HD models
- Deferoxamine (DFO): FDA-approved iron chelator
- Deferasirox: Oral iron chelator
- Clioquinol: Blood-brain barrier permeable chelator
| Compound |
Mechanism |
Development Status |
| Ferrostatin-1 |
Radical trapping |
Research use |
| Liproxstatin-1 |
Lipoxygenase inhibition |
Preclinical |
| CoQ10 |
Antioxidant |
Clinical trials |
| Vitamin E |
Antioxidant |
Approved supplement |
- Selenium supplementation
- Sulforaphane induction of GPX4
- NAPDH generation enhancement
- Ferritin levels
- Lipid peroxidation products (MDA, 4-HNE)
- Iron regulatory proteins
- 4-HNE-protein adducts
- Iron concentration
- GPX4 activity
- Primary neuron cultures
- iPSC-derived neurons
- Organoid models
- GPX4 knockout mice
- Iron overload models
- Rotenone/6-OHDA models
The study of Ferroptosis Sensitive Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Dixon SJ, et al. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 149(5):1060-1072.
- Stockwell BR, et al. (2017). Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 171(2):273-285.
- Weiland A, et al. (2019). Ferroptosis in Neuronal Cell Death and Neurodegeneration. Oxid Med Cell Longev. 2019:9295642.
- Yang WS, et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell. 156(1-2):317-331.
- Cao JY, Dixon SJ. (2016). Mechanisms of ferroptosis. Cell Mol Life Sci. 73(11-12):2195-2209.